The reported statements, read against the company's own industry.
Financials view
Market Capitalization
70.90BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
34.90x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Revenue (TTM)
29.14BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
3.31%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
52-Week Change
-2.95%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
70.90BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
52.09BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
34.90x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Forward P/E
23.90x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Price to Sales (TTM)
2.43x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Price to Book (MRQ)
2.99x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Enterprise to Revenue
1.79x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Enterprise to EBITDA
17.11x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.49×.Updated Jul 19, 2026
Gross Margin
25.04%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Profit Margin
3.31%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Operating Margin
5.43%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Return on Assets (TTM)
3.01%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Return on Equity (TTM)
6.05%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Revenue (TTM)
29.14BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
34.44USDUpdated Jul 19, 2026
Quarterly Revenue Growth
10.70%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Gross Profit (TTM)
7.54BUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
3.16BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
966.00MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
-59.90%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Operating Cash Flow (TTM)
1.47BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
1.16BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Minority Interest (Equity)
8.55BUSDFY2025 · Dec 31, 2025
Revenue
28.43BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
20.91BUSDFY2025 · Dec 31, 2025
Gross Profit
7.52BUSDFY2025 · Dec 31, 2025
Operating Income
2.21BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.25BUSDFY2025 · Dec 31, 2025
Income Tax Expense
91.00MUSDFY2025 · Dec 31, 2025
Net Income
1.16BUSDFY2025 · Dec 31, 2025
EBIT
2.06BUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
3.16BUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
4.52BUSDFY2025 · Dec 31, 2025
Other Operating Expenses
78.00MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
812.00MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.43USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.43USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
812.00MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
812.00MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
1.16BUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
2.00MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
1.70BUSDFY2025 · Dec 31, 2025
Free Cash Flow
1.25BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.94BUSDFY2025 · Dec 31, 2025
Income Tax Paid
62.00MUSDFY2025 · Dec 31, 2025
Interest Paid
944.00MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
1.16BUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
1.01BUSDFY2025 · Dec 31, 2025
Stock-based Compensation
76.00MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
144.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-355.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
73.00MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-409.00MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-447.00MUSDFY2025 · Dec 31, 2025
Net Acquisitions
6.00MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-33.00MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-474.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
7.75BUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-11.84BUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-2.00BUSDFY2025 · Dec 31, 2025
Common Dividends Paid
-518.00MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-36.00MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
399.00MUSDFY2025 · Dec 31, 2025
Shares Outstanding
846.00MSharesUpdated Jul 19, 2026
Float Shares
356.91MSharesUpdated Jul 19, 2026
Shares Short
36.30MSharesUpdated Jul 19, 2026
Short Ratio
3.27days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
9.32%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 4.29%.Updated Jul 19, 2026
% Held by Insiders
0.21%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
98.93%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
2.27BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
2.68USDUpdated Jul 19, 2026
Total Debt (MRQ)
12.64BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
0.6531x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Current Ratio (MRQ)
4.41x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Book Value per Share (MRQ)
13.32USDUpdated Jul 19, 2026
Total Assets
38.48BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
10.68BUSDFY2025 · Dec 31, 2025
Total Liabilities
19.20BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
27.80BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
16.71BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
2.49BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.94BUSDFY2025 · Dec 31, 2025
Accounts Receivable
3.53BUSDFY2025 · Dec 31, 2025
Inventory
4.77BUSDFY2025 · Dec 31, 2025
Accounts Payable
961.00MUSDFY2025 · Dec 31, 2025
Short-term Debt
143.00MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
808.00MUSDFY2025 · Dec 31, 2025
Long-term Debt
12.48BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
4.22BUSDFY2025 · Dec 31, 2025
Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025
Retained Earnings
-7.00MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
19.29BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
32.81USDUpdated Jul 19, 2026
52-Week High
50.88USDUpdated Jul 19, 2026
52-Week Change
-2.95%
vs all stocks
Updated Jul 19, 2026
50-Day MA
37.94USDUpdated Jul 19, 2026
200-Day MA
42.11USDUpdated Jul 19, 2026
Avg 10-Day Volume
5.50MSharesUpdated Jul 19, 2026
Avg 30-Day Volume
8.75MSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
1.14USDUpdated Jul 19, 2026
Other Income / Expense
-152.00MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Much of what it owns is goodwill from past deals, large next to its equity.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.39: safe zoneNotable
Altman Z-Score: 3.39
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $70.9B, higher than 95% of all stocks globallySignificant
Market cap (USD): 70,896,633,910Global P95: 25,614,208,870.135
Revenue is $29.14B, higher than 95% of all stocks globallySignificant